WAVE Life Sciences Ltd Stock
Price
Target price
€10.60
€10.60
-1.850%
-0.2
-1.850%
€18.64
06.02.26 / Stuttgart Stock Exchange
WKN: A1436W / Symbol: WVE / Name: WAVE Life / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
WAVE Life Sciences Ltd Stock
A loss of -1.850% shows a downward development for WAVE Life Sciences Ltd.
The stock is one of the favorites of our community with 22 Buy predictions and 1 Sell predictions.
As a result the target price of 18 € shows a very positive potential of 69.81% compared to the current price of 10.6 € for WAVE Life Sciences Ltd.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for WAVE Life Sciences Ltd stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of WAVE Life Sciences Ltd in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of WAVE Life Sciences Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| WAVE Life Sciences Ltd | -1.850% | - | -13.115% | 3.922% | -28.859% | 175.253% | 21.143% |
| Intellia Therapeutics Inc | 1.610% | -3.634% | -0.813% | 8.321% | 28.081% | -74.075% | -82.235% |
| Arbutus Biopharma Corp. | -4.900% | 4.049% | -16.576% | 6.332% | -15.454% | 35.463% | -4.959% |
| Protalix Biotherapeutics Inc. | 7.020% | 0.820% | 41.379% | -3.073% | 60.784% | 66.554% | -39.109% |
Comments
WAVE Life Sciences (NASDAQ:WVE) is now covered by analysts at Bank of America Corporation. They set a "buy" rating and a $38.00 price target on the stock.
Show more
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its price target raised by analysts at Cantor Fitzgerald from $34.00 to $41.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for WVE provided by MarketBeat
WAVE Life Sciences (NASDAQ:WVE) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Show more
Ratings data for WVE provided by MarketBeat
